Skip to main content

Zingiber officinale acts as a nutraceutical agent against liver fibrosis



Zingiber officinale Roscoe (ginger) (Zingiberaceae) has been cultivated for thousands of years both as a spice and for medicinal purposes. Ginger rhizomes successive extracts (petroleum ether, chloroform and ethanol) were examined against liver fibrosis induced by carbon tetrachloride in rats.


The evaluation was done through measuring antioxidant parameters; glutathione (GSH), total superoxide dismutase (SOD) and malondialdehyde (MDA). Liver marker enzymes; succinate and lactate dehydrogenases (SDH and LDH), glucose-6-phosphatase (G-6-Pase), acid phosphatase (AP), 5'- nucleotidase (5'NT) and liver function enzymes; aspartate and alanine aminotransferases (AST and ALT) as well as cholestatic markers; alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), total bilirubin were estimated. Liver histopathological analysis and collagen content were also evaluated. Treatments with the selected extracts significantly increased GSH, SOD, SDH, LDH, G-6-Pase, AP and 5'NT. However, MDA, AST, ALT ALP, GGT and total bilirubin were significantly decreased.


Extracts of ginger, particularly the ethanol one resulted in an attractive candidate for the treatment of liver fibrosis induced by CCl4. Further studies are required in order to identify the molecules responsible of the pharmacological activity.

1. Background

Liver plays a pivotal role in regulating various physiological processes in the body such as metabolism, secretion and storage. It has great capacity to detoxicate toxic substances and synthesize useful principles. Therefore, damage on the liver inflicted by hepatotoxic agents is of grave consequences [1].

Evidences developed over the last years have suggested that various forms of liver injuries may be caused by free radical formation and subsequent oxidative stress. It is believed that reactive oxygen species (ROS), such as hydroxyl radical, superoxide radical anion and nitric oxide may injure cell membranes through lipid peroxidation [2]. Apparently ROS modify or damage biomolecules, i.e., proteins, lipids, carbohydrates and DNA [3]. Oxidative stress lead to the formation of glycoxidation products, including advanced glycation end products (AGEs - among them -(carboxymethyl) lysine (CML) is best known), and advanced oxidation protein products (AOPPs). The receptor for advanced glycation end products (RAGE) is a signal transduction receptor that binds both AGEs and AOPPs. RAGE is expressed by hepatic stellate cells and myofibroblasts, which are the relevant cells for fibrogenesis of chronic liver disease. Both AGEs and AOPPs trigger the inflammatory response via interaction with RAGE and by causing activation of nuclear factor NF-κB [4]. Since advanced oxidation protein products are not only markers of oxidative stress but also act as inflammatory mediators [5], the knowledge of AOPPs pathophysiology in chronic liver disease could provide valuable information with respect to the relationship between oxidative stress and the inflammatory response related to liver fibrosis [6].

Carbon tetrachloride (CCl4), as a xenobiotic, caused oxidative stress and may injuries hepatic cells [7]. Many studies have established the fact that CCl4 is metabolized in the liver into a highly reactive substance, trichloromethyl, which initiate free radicals that mediate lipid peroxidation [8].

For this reason, anti-oxidation is an extremely significant activity which can be used as a preventive agent against diseases [9]. In spite of tremendous advances in modern medicine, there are no effective drugs available to improve liver function, offer protection or help to regenerate hepatic cells [1]. In absence of reliable liver-protective drugs, therefore, attention is focused on natural antioxidants. Natural antioxidants are polyphenol compounds which are found in all plants [10].

Ginger (Zingiber officinale Roscoe; Zingiberaceae) has been used as a spice for over thousand years [11]. Its roots contain polyphenol compounds (6-gingerol and shogaols), which have a high antioxidant activity [12]. In addition, ginger reported as detoxifying agent against alcohol abuse [13] and bromobenzene intoxication [14]. Matsuda et al. [15] and Habib et al. [16] mentioned its antidiabetic, antihyperlipidimic and hepatic anticancer effect.

According to glossary produced by American Diabetics and Association, neutriceutics are substances considered as food or a part of it that offers health or medicinal benefit, including prevention and treatment of diseases [17]. Some of the natural products find their use not as pharmaceuticals (real medicine) but as a novel class of dietary supplements or nutraceuticals that fall well into the concept of functional foods. Ginger has been listed in ''Generally Recognized as Safe'' (GRAS) document of the US FDA, where a dose of 0.5-1.0 g of ginger powder ingested 2-3 times for periods ranging from 3 months to 2.5 years did not cause any adverse effects [18].

Despite the favorable ethnopharmacological properties of ginger, its protective effect against liver fibrosis has not previously been explored and its role as diminished factor of fibrosis could be a marker of therapeutic benefit. The aim of the present study was to evaluate successive ginger extracts (petroleum ether, chloroform and ethanol) against liver fibrosis induced by CCl4 in rats. The evaluation was done through measuring certain antioxidant parameters, hepatic marker enzymes, liver function indices, cholestatic biomarkers and histological analysis of the liver sections.

2. Material and methods

2.1. Chemicals

All chemicals in the present study were of analytical grade, product of Sigma (US), Merck (Germany) and BDH (England).

2.2. Plant collection

Ginger rhizomes were purchased from local market (Hyper One, 6th October City, Egypt) and identified by Dr. Manal Shabana, Phytochemistry and Plant Systematic Department, National Research Center, Egypt. Voucher specimen (ZOR-2010) was deposited as a reference at Therapeutic Chemistry Department, NRC. Dried rhizomes were ground in a grinder with 2 mm diameter mesh and kept in tightly closed container until needed.

2.3. Plant Extraction

The dried powdered rhizomes (500 g) were successively extracted in a Soxhlet apparatus using solvents of increasing polarities: petroleum ether (40-60°C), chloroform and 95% ethanol for 72 h of each solvent [19]. Solvent removal was carried by evaporation under reduced pressure at 40°C yielding semisolid residues of 1.3, 0.80 and 2.35% w/w, respectively.

2.4. Phytochemical screening

All extracts were tested for carbohydrates, sterols, terpenes [20], flavonoids, tannins, oils [21] and alkaloids [22].

2.5. Animals

Male Wistar albino rats (100: 120 g) were selected for this study. They were obtained from the Animal House, National Research Center, Egypt. All animals were kept in controlled environment of air and temperature with access of water and diet. Anesthetic procedures and handling with animals complied with the ethical guidelines of Medical Ethical Committee of National Research Centre in Egypt (Approval no: 10031).

2.6. Doses and route of administration

Administration regimen was twice a week for six consecutive weeks. CCl4 (0.5 ml/kg) was suspended in olive oil (1:9 v/v) and injected intraperitoneally [23]. Ginger extracts were administrated orally at a dose 200 mg/kg) [14]. Silymarin; a reference herbal drug was orally administered at a dose 100 mg/kg [24].

Normal control group was orally vehicle with 0.5 ml normal physiological saline and intraperitoneally received 0.5 ml olive oil. Control groups treated with ginger extracts were intraperitoneally vehicle with 0.5 ml olive oil. CCl4 group was orally vehicle with 0.5 ml of normal physiological saline.

2.7. Experimental groups

72 male Wistar strain albino rats were used in this study. Animals were divided into 9 groups (8 rats each). Group1 served as normal healthy control rats. Groups 2-4 were normal healthy rats administered with ginger extracts (petroleum ether, chloroform and ethanol). Group 5 injected with CCl4. Groups 6-8 forced at the same time with CCl4 and ginger extracts. Group 9 forced with CCl4 and silymarin drug.

2.8. Sample preparations

Serum sample: Blood collected from each animal by puncture the sublingual vein in clean and dry test tube, left 10 min to clot and centrifuged at 3000 rpm (4°C) for serum separation. The separated serum was stored at -80°C for further determinations of liver function enzymes, cholestatic biomarkers and serum protein.

Liver tissue was homogenized in normal physiological saline solution (0.9% NaCl) (1:9 w/v). The homogenate was centrifuged at 4°C for 5 min at 3000 rpm. The supernatant was used for estimation of liver marker enzymes and the antioxidant parameters.

2.9. Biochemical assays

2.9.1. Antioxidant parameters

Malondialdehyde as a product of polyunsaturated fatty acids oxidation was determined by the method of Buege and Aust [25]. Its concentration was calculated using the extinction coefficient value 1.56 × 105 M-1 cm-1 and read at 535 nm. Glutathione was assayed by the method of Moron et al. [26] using dithiobis-2-nitrobenzoic acid (DTNB) in PBS. The reaction colour was read at 412 nm. Total superoxide dismutase was estimated by method of Nishikimi et al. [27], where the increase in NADH oxidation was measured at 560 nm using its molar extinction coefficient 6.22 × 103 M-1 cm-1.

2.9.2. Hepatic cell organelles markers

Succinate dehydrogenase; a marker for mitochondria was estimated by the method of Rice and Shelton [28], where the reduction of flavin adenine dinucleotide was coupled with a reduction of tetrazolium salt as 2-p-iodophenyl-3-p-nitrophenyl-5-phenyl tetrazolium chloride (INT) and the produced formazan of INT was measured colorimetrically at 490 nm. Lactate dehydrogenase; a marker for cytoplasm was estimated by the method of Babson and Babson [29], where the reduction of nucleoside derived amino acids (NAD) was coupled with the reduction of tetrazolium salt and the produced formazan of INT was measured colorimetrically at 503 nm. The three enzymes, G-6-Pase (microsome marker), acid phosphatase (lysosome marker) and 5'- nucleotidase (plasma membrane marker) were measured colorimetrically as inorganic phosphorus released at 660 nm [3032], respectively.

2.9.3. Serum biomarkers for liver function tests and total protein level

Aspartate and alanine amintransferases were measured by the method of Gella et al. [33], where the transfer of amino group from aspartate or alanine formed oxalacetate or pyruvate, respectively and the developed colour was measured at 520 nm. Total protein was assayed by the method of Bradford [34], where Coomassie Brilliant Blue dye reacted with Bradford reagent and gave a blue complex at 595 nm.

2.9.4. Cholestatic indices

Alkaline phosphatase catalyzed in alkaline medium the transfer of phosphate group from 4-nitrophosphatase to 2-amino-2-methyl-1-propanol (AMP) and librated 4-nitrophenol. The developed colour was measured at 510 nm [35]. GGT was estimated by the method of Szasz [36], where GGT enzyme reacted with L-γ - glutamyl-3-carboxy-p-nitroanilide and glycyl-glycine to give L-γ - glutamyl-glycyl-glycine and 5-amino-2-nitrobenzoate. The decrease in absorbance was read at 450 nm at 1 min intervals for 3 minutes. Total bilirubin was measured by the method of Doumas et al. [37], where it reacted with diazotized sulfanilic acid in the presence of caffeine with final azo-pigment product. The developed colour was read at 546 nm.

2.10. Histopathological study

Liver slices were fixed in 10% paraformaldehyde and embedded in paraffin wax blocks. Sections of 5 μm thick were stained with hematoxylin & eosin (H&E) and Masson's trichrome, then examined under light microscope for determination of pathological changes [38]. Collagen content was determined in Masson's trichrome sections and expressed as collagen volume, where volume of collagen (%) = number of points failing on 10 successive fields/number of points in the reticule (1 cm2 eye piece reticule) × 100 [39].

2.11. Statistical analysis and calculations

All data were expressed as mean ± SD of eight rats in each group. Statistical analysis was carried out by one-way analysis of variance (ANOVA), Costat Software Computer Program. Significance difference between groups was at p < 0.05.

% change = control mean - treated mean/control mean × 100.

% improvement = treated mean - injured mean/control mean × 100.

3. Results

3.1. Phytochemical screening

Phytochemical screening of ginger ethanolic extract revealed abundant presence of flavonoids and tannins. High concentration of carbohydrates and moderate concentration of alkaloids were recorded. Chloroformic extract contained moderate concentrations of sterols and terpenes, while petroleum ether one contained moderate lipids content (Table 1).

Table 1 Phytochemical screening of successive ginger extracts

3.2. Extracts safety

Normal healthy rats administrated with ethanol and chloroform extracts recorded insignificant changes in all parameters under investigation revealing extracts safety. Petroleum ether extract showed significant changes in AP, AST, ALT, liver and body weight (Additional file 1 Tables S1-S5).

3.3. Effect of Zingiber officinale on hepatic antioxidant levels

CCl4 group recorded significant decrease in glutathione (63.63%) and total SOD (49.73%) levels, while malondialdehyde showed significant increase by 38.00% (Table 2). Treatment with ethanol extract improved MDA and SOD levels by 60.56 and 10.70%, respectively. Glutathione enhanced after treatment with chloroform and ethanol extracts by 32.70 and 27.97%. Treatment with silymarin recorded improvement in GSH, MDA and SOD by 40.08, 35.21 and 3.84%, respectively.

Table 2 Effect of Zingiber officinale extracts on hepatic antioxidant levels in CCl4 treated rats

3.4. Efficiency of Zingiber officinale on hepatic marker enzymes

Fibrotic liver induced by CCl4 recorded significant decrease in SDH, LDH, G-6-Pase, AP and 5'NT by 22.65, 32.50, 24.40, 35.13 and 47.22%, respectively (Table 3). Treatment with ginger extracts recorded improvement in all marker enzymes, whereas ethanolic extract showed higher improvement percentages than the other ones. It recorded enhancement by 13.85, 9.42, 20.60 and 25.41% for SDH, G-6-Pase, AP and 5'NT, respectively. Contradictory, LDH enzyme recorded higher improvement level after treatment with petroleum ether extract (29.9%) (Table 3). Treatment with silymarin improved SDH, LDH, G-6-Pase, AP and 5'NT by 6.39, 23.76, 8.69, 8.18 and 17.77%, respectively.

Table 3 Effect of Zingiber officinal e extracts on hepatic marker enzymes in CCl4 treated rats

3.5. Potency of Zingiber officinale in improving liver function enzymes and serum protein

CCl4 group, showed significant increase in AST and ALT levels by 88.34 and 43.52%, respectively (Table 4). However, serum total protein was insignificantly increased by 8.93, 6.97 and 3.91% after treatment with ethanol, chloroform and petroleum ether extracts, respectively. The observed changes in liver function enzymes showed that ethanol extract recorded the most improvement percentages than the other extracts. AST and ALT were ameliorated by 31.11 and 21.26%, while serum protein was improved by 15.19, 13.24 and 12.39% for the three extracts, respectively. Silymarin enhanced AST, ALT and total protein levels by 36.66, 22.84 and 12.39%, respectively.

Table 4 Effect of Zingiber officinale extracts on liver function enzymes and total protein level in serum of CCl4 treated rats

3.6. Efficacy of Zingiber officinale on serum cholestatic markers

As compared to normal healthy rats, CCl4 group recorded significant increase in GGT, ALP and total bilirubin by 55.70, 46.61 and 157.14%, respectively (Table 5). Improvement in serum cholestatic biomarkers after treatment revealed that all extracts shared in improvement by high percentages. Treatment with ethanol extract recorded the highest improving percent in GGT and total bilirubin (53.99 and 154.76%). ALP enhanced by 33.81, 44.74 and 41.29% after treatment with ethanol, chloroform and petroleum ether extracts, respectively. GGT, ALP and total bilirubin recorded improvement percentages reached to 43.85, 33.81 and 152.38% after silymarin treatment.

Table 5 Effect of Zingiber officinale extracts on serum cholestatic markers in CCl4 treated rats

3.7. Potency of Zingiber officinale in improving liver and relative body weights

CCl4 intoxicated rats showed significant increase in liver weight (LW) and its ratio over body weight (LW/BW) by 21.21 and 69.39%, respectively. However body weight (BW) recorded significant decrease by 28.37% (Table 6). Regarding to the recorded changes in LW, BW and their ratios, ethanol extract showed improvement by 17.92, 12.88 and 39.89%, respectively. Treatment with petroleum ether extract showed enhancement by 14.80, 10.66 and 34.42%, while chloroform extract recorded enhancement values by 7.07, 3.92 and 34.69% (Table 6). Silymarin treatment improved LW, BW and their ratio by 0.16, 25.55 and 43.16%, respectively.

Table 6 Effect of Zingber officinale extracts on liver and body weights of CCl4 treated rats

3.8. Effect of Zingiber officinale on collagen content in CCl4 treated liver

Normal healthy liver of control and control treated with ethanol and chloroform extracts of ginger recorded 5% collagen deposition. Normal liver treated with petroleum ether extract exerted 10% collagen content. CCl4 injured liver revealed 70% collagen deposition. Treatment with ethanol, chloroform, petroleum ether extracts and silymarin recorded decrease in collagen content by 85.71, 64.28, 28.57 and 78.57%, respectively (Figure 1).

Figure 1
figure 1

Percentages of collagen deposition in normal and CCl 4 treated livers. Normal control (I), control treated with ethanol extract (II), control treated with chloroform extract (III), control treated with petroleum ether extract (IV), CCl4 group(V), CCl4 treated with ethanol extract (VI), CCl4 treated with chloroform extract (VII), CCl4 treated with petroleum ether extract (VIII) and CCl4 treated with silymarin (IX).

3.9. Effect of Zingber officinale on liver morphology

CCl4 induced changes in liver morphology as compared with normal healthy one (Figure 2-a). Liver colour had changed from normal reddish brown to more or less light brown; a stage of steatosis. The liver enlarges in size and lost it's smoothly surface. Scattered patches of inflammations and pale yellowish fibrotic areas had been seen along with long fibrotic girdle surrounded the outer liver margin (Figure 2-b). Treatment with ethanol extract had returned the liver to it's smoothly appearance, normalized its colour and size and diminished the fibrotic spots to be minimal (Figure 2-c). Chloroform extract of ginger improved the morphological structure of the liver, while a fibrotic area was seen in the hepatic core (Figure 2-d). Petroleum ether extract showed the worst appearance, where large patches as well as many spots of fibrosis were scattered along the liver (Figure 2-e). Treatment with silymarin minimally improved the morphological structure of the liver. Many area of fibrosis along the whole liver surface were spread and marked inflammations along the border of the hepatic lobes were observed (Figure 2-f).

Figure 2
figure 2

Morphological structure of normal and CCl 4 treated livers. Normal control (a), CCl4 injured liver (b), CCl4 treated with ethanol extract (c), CCl4 treated with chloroform extract (d), CCl4 treated with petroleum ether extract (e) and CCl4 treated with silymarin drug (f).

3.10. Liver histopathological analysis

Fig. (3 a, b) showed liver section of control healthy rats with normal hepatic lobular architecture. The hepatocytes were within normal limits and arranged in thin plates. The hepatocytes were separated by narrow blood sinusoids lined by endothelial cells. Portal tracts extend with no fibrous tissue or lymphocytes deposition. Healthy rats treated with ethanolic extract showed normal hepatic lobular architecture. The hepatocytes were within normal limits and no hydropic or steatosis changes. Portal tracts were normal and no sign of fibrosis (Figure 3 c, d). Treatment with chloroform extract of ginger recorded more or less normal hepatocytes architecture (Figure 3 e, f). Petroleum ether extract caused mild hepatocytes aggregation and lymphocytes infiltrations (Figure 3 g, h).

Figure 3
figure 3

Photomicrograph of H&E and Masson's trichrom stained liver sections (100×) of control (a,b), control treated with ethanol extract (c,d), control treated with chloroform extract (e,f) and control treated with petroleum ether extract (g,h). Central vein (CV). Arrows indicate collagen deposition.

Injured liver with CCl4 showed portal loss of hepatic lobular architecture. Ballooning of hepatocytes, deformed cord arrangement and disturbed sinusoids were seen. The hepatocytes showed marked degree of hydropic, steatotic changes and massive necrosis. Portal tracts were extended with marked numbers of chronic inflammatory cells and fibrous tissue. There were porto-portal and porto-central fibrosis. Fibrosis was markedly presented by 70% (Figure 4 a, b, c).

Figure 4
figure 4

Photomicrograph of H&E and Masson's trichrom liver sections (100×) of CCl 4 intoxicated rats (a,b,c), CCl 4 treated with ethanol extract (d,e) and CCl 4 treated with chloroform extract (f,g), CCl 4 treated with petroleum ether extract (h,i), CCl 4 treated silymarin drug (j,k). Arrows indicate collagen deposition and lymphocytes infiltrations. Small arrows indicate fat vacuoles deposition and hepatocytes foamy appearance.

Treatments of injured liver with the ethanol extract showed well formed nucleated hepatocytes arranged in cord with obvious sinusoidal arrays. Minimal fat vacuoles and minimal inflammatory lymphocyte infiltrations were observed. Fibrosis reached to 10% (Figure 4 d, e). Chloroform extract partly preserved the hepatic normal architecture. Mild degrees of steatosis and hydropic changes were recorded. The hepatocytes were still swollen with narrow sinusoids. Portal tracts were extended with moderate fibrous tissue reached to 25% (Figures 4 f, g). Petroleum ether extract showed narrow sinusoids, ballooning and foamy appearance of heapatocytes. Portal tracts were extended with moderate fibrous tissue reached to 50% (Figure 4 h, i). CCl4 group treated with silymarin showed well arranged cord of nucleated hepatocytes and sinusoids, while mild fibrotic tissue was still present (15%) (Figure 4 j, k).

4. Discussion

Hepatoprotective studies showed that plants have active ingredients that are capable of free radical scavenging in living systems [10]. Flavonoids, sterols, triterpenes and alkaloids as antioxidative compounds are rich in most plants [40]. In the present study and in accordance with Anosike et al. [41], high content of these compounds was recorded in the ethanol extract of ginger followed by chloroform one suggesting their potential role as antioxidative agents.

CCl4 is one of an extensively environmental toxicant. The reactive metabolite trichloromethyl radical (CCl3-) has been formed from the metabolic conversion of CCl4 by cytochrome P-450. This reactive metabolite initiates the peroxidation of membrane poly-unsaturated fatty acids (PUFA), generates PUFA radicals, covalently binds to membrane lipids and proteins and generates ROS [42]. Evidence suggests that various enzymatic and non-enzymatic systems have been developed by the cell to attenuate ROS. However, when a condition of oxidative stress establishes, the defense capacities against ROS becomes insufficient. Therefore, ROS affects the antioxidant defense mechanisms, reduces the intracellular concentration of GSH, decreases the activity of SOD and enhances lipid peroxidation [43]. In agreement with these explanations, the observed decrease in SOD was recorded in CCl4 treated rats that may be due to inactivation of the antioxidative enzymes. This may cause an increased accumulation of superoxide radicals, which could further stimulate lipid peroxidation. Decrease in GSH activity might be due to decrease availability of GSH resulted during the enhanced lipid peroxidation processes.

Treatment with ginger extracts normalized the antioxidant levels through their rich of flavonoids that have the ability to scavenge free radicals. Silymarin as an antioxidant flavonoid complex derived from the herb milk thistle (Silybum marianum), has the ability to attenuate free radicals elevation, chelates metal ions, inhibits lipid peroxidation and prevents liver glutathione depletion [44].

ALT and AST had been reported to be sensitive indicators of liver injury [45]. Significant elevation of ALT and AST after CCl4 intoxication was in agreement with those reported studies of Opoku et al. [40] and Gowri Shankar et al. [42]. In addition, Romero et al. [46] showed that CCl4 intoxication induced changes in the process of protein synthesis. Hence, increase in total protein content can be deemed as a useful index of the severity of cellular dysfunction in liver diseases as clearly shown in our studies. Stimulation of protein synthesis has been advanced as a contributory self healing mechanism, which accelerates liver regeneration process [47].

Enhancement of cholestatic biomarkers; ALP, GGT and bilirubin were observed in the present study. This was in agreement with Reyes-Gordillo et al. [48] who recorded significant increase in cholestasis biomarker after intoxication of rats with CCl4. Leonard et al. [49] confirmed GGT and bilirubin as indicators of bile duct lesions. Hamed [50] added that GGT alone is a poor indicator of cytotoxicity and suggested the combination of other markers like AST, ALT and LDH for accurate detection and early diagnosis. Opoku et al. [40] and Gowri Shankar et al. [42] explained serum enzymes elevation to the increase in hepatic cell membrane fluidity that led to enzyme release into circulation.

Treatment with ginger extracts attenuated the increased level of serum enzymes and caused a subsequent recovery towards normalization. This give an additional support that ginger extracts are able to condition the hepatocytes, accelerate regeneration of parenchyma cells, protect against membrane fragility and decrease leakage of the enzymes into circulation. Therefore, plant extracts acted by the same mode of action of silymarin [42].

Stressful condition also contribute to the oxidative inactivation of G-6-Pase and 5'- nucleotidase [51]. Inhibition of G-6-Pase and 5'NT activities, in our study, are in agreement with the findings of Opoku et al. [40] and Nkosi et al. [52]. The decreased activities of these marker enzymes during CC14 poisoning confirm microsomal and plasma membrane damage. Though these two enzymes are active in two different metabolic pathways, their functional integrity depends on the chemical composition and physical status of the lipid environment where they are embedded. The decrease in membrane phospholipids due to an increase in phospholipase A2 and C and increased lipid peroxidation could be the reason for the decreased enzyme activities [53]. The observed decrease in SDH after CCl4 intoxication was in parallel with the finding of Rusu et al. [54]. This decrease in enzyme activity was attributed to the increase in free radicals that affected the inner mitochondrial membrane and intracellular calcium stores led to structural and functional disorganization, over all loss in energy production, irreversible damage, and loss of enzymatic activity [55, 56]. Rusu et al. [54] and De-Andrade Belo et al. [57] confirmed the decrease in hepatic LDH after CCl4 intoxication. Enzyme inhibition was mainly due to increase membrane fluidity as a result of ROS involvement, leads to enzyme leakage into circulation [50]. The decrease in acid phosphatase enzyme activity was in agreement with Kataria and Singh [58] who observed the same alteration in AP after CCl4 induction. Achliya et al. [59] mentioned that the high level of serum AP indicated its inhibition in hepatocytes. The same authors explained the repair mechanisms after treatment to the rise of phospholipids that coupled with thymidylate synthetase and thymidine kinase which confirmed liver regeneration.

Regulatory effect of ginger extracts and silymarin on hepatic marker enzymes was documented in our study as free radicals scavengers [60] that could in turn normalize microsomes, lysosomes, mitochondria and plasma membranes permeability and integrity which lead to restore the hepatic enzymes to its normal levels.

The most commonly associated characteristic of liver fibrosis is the increased deposition of collagens. During liver fibrosis, altered collagen synthesis at both mRNA and protein levels is observed, with a dramatic increase in type I collagen along with smaller, but significant, increases in type III collagen. This increase in collagen deposition gave an additional support of the observed increase in liver weight and its ratio over body weight. The excess deposition of extracellular matrix proteins disrupts the normal architecture of the liver, alters its normal function and ultimately leading to pathophysiological damage [61]. The most remarkable pathological characteristics of CCl4 -induced hepatotoxicity are massive centrilobular necrosis, ballooning degeneration, cellular infiltration and steatosis [42]. This was in accordance with the present finding of massive deformation of hepatic cells architecture. In ginger and silymarin treated groups, hepatocyte degeneration, necrosis and infiltration of inflammatory cells were all apparently ameliorated. Collagen deposition was markedly reduced. Minimal deposition of fat vacuoles was apparently observed. Silymarin has anti-fibrotic and anti inflammatory effects, inhibit activation of hepatic stellate cells through the expression of transforming growth factor-beta1 and stabilization of mast cells [62]. We compare the anti-fibrogenic effects of silymarin with extracts and the results exhibited that ethanol extract had higher potency in inhibiting collagen deposition and fibrosis severity.


Ginger has the ability to down regulate free radicals elevation, improve liver and cholestatic biomarkers, ameliorate hepatic marker enzymes, reduce collagen deposition, fibrosis severity and normalize the hepatic cells architecture. Ginger ethanolic extract recorded the most potent effect in improving the selected parameters. The hepatoprotective effect of Z. officinale demonstrated in this study may explore its nutraceutical role in human diet. Therefore, further studies are need for its clinical application.


  1. Shanmugasundaram P, Venkataraman S: Hepatoprotective and antioxidant effects of Hygrophila auriculata (K. Schum) Heine acanthaceae root extract. J Ethnopharmacol. 2006, 104: 124-128. 10.1016/j.jep.2005.08.058.

    Article  CAS  Google Scholar 

  2. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007, 39: 44-84. 10.1016/j.biocel.2006.07.001.

    Article  CAS  Google Scholar 

  3. Bhadauria M, Nirala SK, Shukla S: Multiple treatment of propolis extract ameliorates carbon tetrachloride induced liver injury in rats. Food Chem Toxicol. 2008, 46: 2703-2712. 10.1016/j.fct.2008.04.025.

    Article  CAS  Google Scholar 

  4. Hyogo H, Yamagishi S: Advanced glycation end products (AGEs) and their involvement in liver disease. Curr Pharm Des. 2008, 14: 969-972. 10.2174/138161208784139701.

    Article  CAS  Google Scholar 

  5. Fialova L, Malbohan I, Kalousova M, Soukupova J, Krofta L, Stipek S, Zima T: Oxidative stress and inflammation in pregnancy. Scand J Clin Lab Invest. 2006, 66: 121-127. 10.1080/00365510500375230.

    Article  CAS  Google Scholar 

  6. Zuwała-Jagiełło J, Pazgan-Simon M, Krzysztof Simon K, Maria Warwas M: Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcohol-related and HCV-related cirrhosis. Acta Biochimica Polonica. 2011, 58: 59-65.

    Google Scholar 

  7. Kanter M, Coskun O, Budancamanak M: Hepatoprotective effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and liver enzymes in carbon tetrachloride-treated rats. World J Gastroenterol. 2005, 11: 6684-6688.

    Article  Google Scholar 

  8. Nevin KG, Vijayamma L: Effect of Aerva lanata against hepatotoxicity of carbon tetrachloride in rats. Environ Toxicol Pharmacol. 2005, 20: 471-477. 10.1016/j.etap.2005.05.010.

    Article  CAS  Google Scholar 

  9. Halliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement and significance. Am J Clin Nut. 1993, 57: 715-725.

    Google Scholar 

  10. Mitra SK, Venkataranganna MV, Sundaram R, Gopumadhavan S: Effect of HD-03, a herbal formulation, on the antioxidant defense system in rats. Phytother Res. 1998, 12: 114-117. 10.1002/(SICI)1099-1573(199803)12:2<114::AID-PTR206>3.0.CO;2-8.

    Article  Google Scholar 

  11. Bartley J, Jacobs A: Effects of drying on flavour compounds in Australian-grown ginger (Zingiber officinale). J Sci Food Agric. 2000, 80: 209-215. 10.1002/(SICI)1097-0010(20000115)80:2<209::AID-JSFA516>3.0.CO;2-8.

    Article  CAS  Google Scholar 

  12. Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S: Antioxidant activity of a ginger extract (Zingiber officinale). Food Chem. 2007, 102: 764-770. 10.1016/j.foodchem.2006.06.023.

    Article  CAS  Google Scholar 

  13. Shati AA, Elsaid FG: Effects of water extracts of thyme (Thymus vulgaris) and ginger (Zingiber officinale Roscoe) on alcohol abuse. Food Chem Toxicol. 2009, 47: 1945-9. 10.1016/j.fct.2009.05.007.

    Article  CAS  Google Scholar 

  14. El-Sharaky AS, Newairy AA, Newairy AA, Kamel MA, Eweda SM: Protective effect of ginger extract against bromobenzene-induced hepatotoxicity in male rats. Food Chem Toxicol. 2009, 47: 1584-1590. 10.1016/j.fct.2009.04.005.

    Article  CAS  Google Scholar 

  15. Matsuda A, Wang Z, Takahashi S, Tokuda T, Miura N, Hasegawa J: Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Sci. 2009, 84: 903-907. 10.1016/j.lfs.2009.04.004.

    Article  CAS  Google Scholar 

  16. Habib SH, Makpol S, Abdul Hamid NA, Das S, Ngah WZ, Yusof YA: Ginger extract (Zingiber officinale) has anti-cancer and anti-inflammatory effects on ethionine-induced hepatoma rats. Clinics (Sao Paulo). 2008, 63: 807-813.

    Article  Google Scholar 

  17. Bloch A, Thomson CA: Position of the American Diabetic Association: phytochemicals and functional foods. J Am Diet and Assoc. 1995, 95: 406-493.

    Article  Google Scholar 

  18. Langner E, Greifenberg S, Gruenwald J: Ginger: history and use. Adv Ther. 1998, 15: 25-30.

    CAS  Google Scholar 

  19. Sharififar F, Moshafi MH, Dehghan-Nudehe G, Ameri A, Alishahi F, Pourhemati A: Bioassay screening of the essential oil and various extracts from 4 spices medicinal plants. Pak J Pharmcol Sci. 2009, 22: 317-322.

    CAS  Google Scholar 

  20. Nadal NG: Sterols of Spirulina maxima. Phytochemistry. 1971, 10: 2537-2538. 10.1016/S0031-9422(00)89903-3.

    Article  Google Scholar 

  21. Seikel MK: Chromatographic methods of separation, isolation and identification of flavonoid compounds. The Chemistry of Flavonoid Compounds. 1962, Macmillan Co, New York, 34-

    Google Scholar 

  22. Trease GEM, Evans WC: Trease and Evans pharmacognosy. 1989, Baillière Tindall, London, 13

    Google Scholar 

  23. Marsillach J, Camps J, Ferré N, Beltran R, Rul A, Mackness B, Michael MM, Joven J: Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol. 2009, 9: 3-10.1186/1471-230X-9-3.

    Article  Google Scholar 

  24. Yuvaraj P, Subramoniam A: Hepatoprotective property of Thespesia populnea against carbon tetrachloride induced liver damage in rats. J Basic Clin Physiol Pharmacol. 2009, 20: 169-177. 10.1515/JBCPP.2009.20.2.169.

    Article  CAS  Google Scholar 

  25. Buege JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol. 1978, 52: 302-310.

    Article  CAS  Google Scholar 

  26. Moron MS, Depierre JW, Mannervik B: Level of glutathione, glutathione reductase and glutathone-S-transferase activities in rat lung and liver. Biochimica Biophysica Acta. 1979, 582: 67-78.

    Article  CAS  Google Scholar 

  27. Nishikimi M, Rae NA, Yagi K: The occurrence of superoxide anion in the action of reduced phenazine methosulphate and molecular oxygen. Biochem Biophys Res Commun. 1972, 46: 849-853. 10.1016/S0006-291X(72)80218-3.

    Article  CAS  Google Scholar 

  28. Rice ME, Shelton E: Comparison of the reduction of two tetrazolium salts with succinoxidase activity of tissue homogenates. J Nat Cancer Inst. 1957, 18: 117-125.

    CAS  Google Scholar 

  29. Babson AL, Babson SR: Kinetic colorimetric measurement of serum lactate dehydrogenase activity. Clin Chem. 1973, 19: 766-769.

    CAS  Google Scholar 

  30. Swanson MA: Glucose-6-phosphatase from liver. Methods in Enzymology. 1955, Academic press, NY, 2: 541-543.

    Google Scholar 

  31. Wattiaux R, De Duve C: Release of bound hydrolase by means of Triton X-100. Biochem J. 1956, 63: 606-608.

    Article  CAS  Google Scholar 

  32. Bodansiky O, Schwartz MK: Comparative effects of L-histidine on the activities of 5-nucleotidase and alkaline phosphatase. J Biol Chem. 1963, 238: 3420-3427.

    Google Scholar 

  33. Gella FJ, Olivella T, Cruz PM, Arenas J, Moreno R, Durban R, Gomez JA: A simple procedure for routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clin Chem Acta. 1985, 153: 241-247. 10.1016/0009-8981(85)90358-4.

    Article  CAS  Google Scholar 

  34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.

    Article  CAS  Google Scholar 

  35. Rosalki SB, Foo AY, Burlina A: Multicenter evaluation of iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem. 1993, 39: 648-652.

    CAS  Google Scholar 

  36. Szasz G: A kinetic photometric method for serum γ-glutamyl transpeptidase. Clin Chem. 1969, 15: 124-136.

    CAS  Google Scholar 

  37. Doumas BT, Perry BW, Sasse EA, Straumfjord JV: Standardization in bilirubin assays: evaluation of selected methods and stability of bilirubin solutions. Clin Chem. 1973, 19: 984-993.

    CAS  Google Scholar 

  38. Suzuki H, Suzuki K: Rat hypoplastic kidney (hpk/hpk) induces renal anemia, hyperparathyroidism, and osteodystrophy at the end stage of renal failure. J Vet Med Sci. 1998, 60: 1051-1058. 10.1292/jvms.60.1051.

    Article  CAS  Google Scholar 

  39. Asad M, Shewade DG, Koumaravelou K, Abraham BK, Vasu S, Ramaswamy S: Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats. Acta Pharmacol Sinica. 2001, 22: 488-92.

    CAS  Google Scholar 

  40. Opoku AR, Ndlovu IM, Terblanche SE, Hutchings AH: vivo hepatoprotective effects of Rhoicissus tridentata subsp. cuneifolia, a traditional Zulu medicinal plant, against CCl4-induced acute liver injury in rats. South African J Botany. 2007, 73: 372-377. 10.1016/j.sajb.2007.02.193.

    Article  Google Scholar 

  41. Anosike CA, Obidoa O, Ezeanyika LU, Nwuba MM: Anti-inflammatory and anti-ulcerogenic activity of the ethanol extract of ginger (Zingiber officinale). Af J Biochem Res. 2009, 3: 379-384.

    Google Scholar 

  42. Gowri Shankar GNL, Manavalan R, Venkappayya D, Raj CD: Hepatoprotective and antioxidant effects of Commiphora berryi (Arn) Engl bark extract against CCl4-induced oxidative damage in rats. Food Chem Toxicol. 2008, 46: 3182-3185. 10.1016/j.fct.2008.07.010.

    Article  CAS  Google Scholar 

  43. Manna P, Sinha M, Sil PC: Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Comp Alt Med. 2006, 6: 33-10.1186/1472-6882-6-33.

    Article  Google Scholar 

  44. Mansour HH, Hafez HF, Fahmy NM: Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. J Biochem Mol Biol. 2006, 39: 656-661. 10.5483/BMBRep.2006.39.6.656.

    Article  CAS  Google Scholar 

  45. Yadav NP, Pal A, Shanker K, Bawankule DU, Gupta AK, Darokar MP, Khanuja SPS: Synergistic effect of silymarin and standardized extract of Phyllanthus amarus against CCl4-induced hepatotoxicityin Rattus norvegicus. Phytomedicine. 2008, 15: 1053-1061. 10.1016/j.phymed.2008.08.002.

    Article  CAS  Google Scholar 

  46. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marín N, Romá J: Lipid peroxidation products and antioxidants in human disease. Environ Health Perspectives. 1998, 106: 1229-1234.

    Article  CAS  Google Scholar 

  47. Sharma N, Shukla S: Hepatoprotective potential of aqueous extract of Butea monosperma against CCl4 induced damage in rats. Exp Toxicol Pathol. 2010,

    Google Scholar 

  48. Reyes-Gordillo K, Segovia J, Shibayama M, Vergara P, Moreno MG, Muriel P: Curcumin protects against acute liver damage in the rat by inhibiting NF-kappa B, proinflammatory cytokines production and oxidative stress. Biochem Biophys Acta. 2007, 1770: 989-996.

    Article  CAS  Google Scholar 

  49. Leonard TB, Neptun DA, Popp JA: Serum gamma glutamyl transferase as a specific indicator of bile duct lesions in the rat liver. Am J Pathol. 1984, 116: 262-269.

    CAS  Google Scholar 

  50. Hamed MA: Metabolic profile of rats after one hour of intoxication with a single oral dose of ethanol. J Pharmacol Toxicol. 2011, 6: 158-165.

    Article  CAS  Google Scholar 

  51. Ohyashiki T, Kamata K, Takeuchi M, Matsui K: Contribution of peroxidation products to oxidative inactivation of rat liver microsomal glucose-6-phosphatase. J Biochem. 1995, 118: 508-514.

    CAS  Google Scholar 

  52. Nkosi CZ, Opoku AR, Terblanche SE: Anti-oxidative effects of pumpkin seed (Cucurbita pepo) protein isolate in CCl4-induced liver injury in low-protein fed rats. Phytother Res. 2006, 20: 935-940. 10.1002/ptr.1977.

    Article  CAS  Google Scholar 

  53. Kumaravelu P, Dakshinamoorthy DP, Subramaniam S, Devarajt H, Devaraj NS: Effect of eugenol on drug-metabolizing enzymes of carbon tetrachloride-intoxicated rat liver. Biochem Pharmacol. 1995, 49: 1703-1707. 10.1016/0006-2952(95)00083-C.

    Article  CAS  Google Scholar 

  54. Rusu MA, Tamas M, Puica C, Roman I, Sabadas M: The hepatoprotective action of ten herbal extracts in CCl4 intoxicated liver. Phytother Res. 2005, 19: 744-749. 10.1002/ptr.1625.

    Article  CAS  Google Scholar 

  55. Jewell SA, Bellomo G, Thor H, Orrenius S, Smith MT: Bleb formation in hepatocytes during drug metabolim is caused by disturbances in thiol and calcium ion homeostasis. Science. 1982, 217: 1257-1259. 10.1126/science.7112127.

    Article  CAS  Google Scholar 

  56. Jadon A, Bhadauria M, Shukla S: Protective effect of Terminalia belerica Roxb. and gallic acid against carbon tetrachloride induced damage in albino rats. J Ethnopharmacol. 2007, 109: 214-8. 10.1016/j.jep.2006.07.033.

    Article  CAS  Google Scholar 

  57. De-Andrade Belo MA, Soaresa VE, de Souza LM, Sobreira MFR, Cassol DMS, Toma SB: Hepatoprotective treatment attenuates oxidative damages induced by carbon tetrachloride in rats. Exp Toxicol Pathol. 2010,

    Google Scholar 

  58. Kataria M, Singh LN: Hepatoprotective effect of liv.52 and kumaryasava on varbon tetrachloride induced hepatic damage in rats. Indian J Exp Biol. 1997, 35: 655-657.

    CAS  Google Scholar 

  59. Achliya GS, Kotagale NR, Wadodkar SG, Dorle AK: Hepatoprotective activity of Panchagavya ghrita against carbon tetrachloride induced hepatotoxicity in rats. Indian J Pharmacol. 2003, 35: 308-311.

    Google Scholar 

  60. Banu GS, Kumar G, Murugesan AG: Ethanolic leaves extract of Trianthema portulacastrum l. ameliorates aflatoxin b1 induced hepatic damage in rats. Indian J Clin Biochem. 2009, 24: 250-256. 10.1007/s12291-009-0047-5.

    Article  Google Scholar 

  61. Tsukada S, Parsons CJ, Rippe RA: Invited critical review. Mechanisms of liver fibrosis. Clin Chem Acta. 2006, 364: 33-60. 10.1016/j.cca.2005.06.014.

    Article  CAS  Google Scholar 

  62. Li GS, Jiang WL, Tian JW, Qub GW, Zhu HB, Fu FH: In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Phytomedicine. 2010, 17: 282-288. 10.1016/j.phymed.2009.05.002.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Manal A Hamed.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

TKM, RMH: Participated in the experimental design and final form of manuscript revision. MAH: Design the experiment, participated in the biochemical analysis and data collections. Performed the statistical analysis, drafted and revised the manuscript. MHS: Plant extractions and phytochemical screening test. AFA: Carried out the experiments and participated in data collections under supervision of MAH. All authors read and approved the final manuscript.

Electronic supplementary material


Additional file 1: Effect of successive extracts of Zingiber officinale on certain biochemical parameters in normal control rats. The data provided represent the effect of successive ginger extracts on hepatic antioxidant levels, hepatic marker enzymes, liver function tests, cholestatic indices and liver and body weights in normal healthy rats (DOC 66 KB)

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Motawi, T.K., Hamed, M.A., Shabana, M.H. et al. Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Nutr Metab (Lond) 8, 40 (2011).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: